Cerenome, Inc.
CNSY
$2.49
-$0.21-7.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.20M | 5.18M | 5.21M | 5.26M | 5.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.20M | 5.18M | 5.21M | 5.26M | 5.32M |
| Cost of Revenue | 12.51M | 9.49M | 8.38M | 7.62M | 8.05M |
| Gross Profit | -8.30M | -4.31M | -3.17M | -2.37M | -2.73M |
| SG&A Expenses | 18.10M | 14.58M | 12.13M | 11.09M | 10.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.60M | 24.06M | 20.51M | 18.71M | 18.09M |
| Operating Income | -26.40M | -18.88M | -15.30M | -13.46M | -12.77M |
| Income Before Tax | -26.09M | -11.93M | -22.39M | -20.58M | -19.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.09 | -11.93 | -22.39 | -20.58 | -19.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.09M | -11.93M | -22.39M | -20.58M | -19.03M |
| EBIT | -26.40M | -18.88M | -15.30M | -13.46M | -12.77M |
| EBITDA | -25.95M | -18.49M | -14.85M | -12.81M | -12.00M |
| EPS Basic | -4.42 | -2.50 | -739.32 | -750.69 | -758.81 |
| Normalized Basic EPS | -2.76 | -0.28 | -596.67 | -603.77 | -608.84 |
| EPS Diluted | -4.43 | -3.29 | -740.11 | -751.47 | -759.69 |
| Normalized Diluted EPS | -2.76 | -1.56 | -597.94 | -605.05 | -610.12 |
| Average Basic Shares Outstanding | 23.35M | 18.39M | 11.76M | 6.57M | 2.58M |
| Average Diluted Shares Outstanding | 23.35M | 24.82M | 18.19M | 13.00M | 9.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |